Interscalene Single Shot With Plain Bupivacaine Versus Liposomal Bupivacaine for Arthroscopic Shoulder Surgery
Sponsor: University of Southern California
Listed as NCT03638960, this PHASE4 trial focuses on Postoperative Pain and Shoulder Pain and remains completed. Sponsored by University of Southern California, it has been updated 11 times since 2019, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
May 2024 — Jul 2024 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Oct 2021 — May 2024 [monthly]
Recruiting PHASE4
-
Jan 2021 — Oct 2021 [monthly]
Recruiting PHASE4
▶ Show 6 earlier versions
-
Dec 2020 — Jan 2021 [monthly]
Recruiting PHASE4
Status: Unknown Status → Recruiting
-
Sep 2020 — Dec 2020 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
May 2019 — Sep 2020 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Mar 2019 — May 2019 [monthly]
Not Yet Recruiting PHASE4
-
Oct 2018 — Mar 2019 [monthly]
Not Yet Recruiting PHASE4
Phase: PHASE3 → PHASE4
-
Sep 2018 — Oct 2018 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Southern California
For direct contact, visit the study record on ClinicalTrials.gov .